The Europe Renal Denervation Market is expected to witness market growth of 35.5% CAGR during the forecast period (2022-2028).
Renal denervation minimally invasive operation is proving to be a promising new non-drug treatment option for controlling blood pressure in individuals with resistant hypertension, however, long-term blood pressure control effects of renal denervation for resistant hypertension have yet to be evaluated. Various Market players are focusing on analyzing current long-term follow-up data on the use of renal denervation for RH in order to completely examine the efficiency of renal denervation for RH and to provide practical assistance for practitioners who are setting up a renal denervation service. Moreover, ambulatory blood pressure is a preferred choice for blood pressure measurement.
According to Public Health England data, more than one in every four people in England has high blood pressure. Additionally, as per the data shared by the NHS Digital from the 2019 Health Survey for England, the proportion of males with hypertension grew from 28% to 30% between 2017 and 2018, while rates for women increased from 25% to 26%. Two-thirds of males aged 75 and up have hypertension of some kind. Lack of physical activity, excessive alcohol intake, smoking, and fast food consumption all contribute to an increased risk of hypertension. In addition, various disorders, such as heart attacks, stroke, and pulmonary arterial hypertension, can be caused by high blood pressure.
CE approval has been granted to a significant number of renal denervation devices across the region. Growing R&D initiatives to produce efficient gadgets are a major driver driving the Market 's growth. The introduction of new items in the region is expected to also help the industry to flourish. Rising incidences of drug-resistant hypertension can increase the growth of the Market throughout the forecasting years.
The Germany Market dominated the Europe Renal Denervation Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $92.4 million by 2028. The UK Market is poised to grow at a CAGR of 34.4% during (2022-2028). Additionally, The France Market is expected to witness a CAGR of 36.5% during (2022-2028).
Based on Technology, the Market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the Market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.
By Technology
By Country
Renal denervation minimally invasive operation is proving to be a promising new non-drug treatment option for controlling blood pressure in individuals with resistant hypertension, however, long-term blood pressure control effects of renal denervation for resistant hypertension have yet to be evaluated. Various Market players are focusing on analyzing current long-term follow-up data on the use of renal denervation for RH in order to completely examine the efficiency of renal denervation for RH and to provide practical assistance for practitioners who are setting up a renal denervation service. Moreover, ambulatory blood pressure is a preferred choice for blood pressure measurement.
According to Public Health England data, more than one in every four people in England has high blood pressure. Additionally, as per the data shared by the NHS Digital from the 2019 Health Survey for England, the proportion of males with hypertension grew from 28% to 30% between 2017 and 2018, while rates for women increased from 25% to 26%. Two-thirds of males aged 75 and up have hypertension of some kind. Lack of physical activity, excessive alcohol intake, smoking, and fast food consumption all contribute to an increased risk of hypertension. In addition, various disorders, such as heart attacks, stroke, and pulmonary arterial hypertension, can be caused by high blood pressure.
CE approval has been granted to a significant number of renal denervation devices across the region. Growing R&D initiatives to produce efficient gadgets are a major driver driving the Market 's growth. The introduction of new items in the region is expected to also help the industry to flourish. Rising incidences of drug-resistant hypertension can increase the growth of the Market throughout the forecasting years.
The Germany Market dominated the Europe Renal Denervation Market by Country in 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $92.4 million by 2028. The UK Market is poised to grow at a CAGR of 34.4% during (2022-2028). Additionally, The France Market is expected to witness a CAGR of 36.5% during (2022-2028).
Based on Technology, the Market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the Market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Radiofrequency
- Ultrasound
- Micro-Infusion
- Hospitals
- Specialty Clinics
- Others
- Symplicity
- Enlightn
- Vessix
- Paradise
- Iberis
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Ablative Solutions, Inc.
- Mercator MedSystems, Inc.
- ReCor Medical, Inc.
- Renal Dynamics Limited
- Johnson & Johnson
- Terumo Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Renal Denervation Market by Technology
Chapter 4. Europe Renal Denervation Market by End User
Chapter 5. Europe Renal Denervation Market by Product Type
Chapter 6. Europe Renal Denervation Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Ablative Solutions, Inc.
- Mercator MedSystems, Inc.
- ReCor Medical, Inc.
- Renal Dynamics Limited
- Johnson & Johnson
- Terumo Corporation
Methodology
LOADING...
